Kilitch Drugs (India) Ltd.

Dear Valued Shareholders On behalf of the Board of Directors

I extend a warm welcome to all of you at the 25th Annual General Meeting of ourCompany.

Although the money market situation across the world remains sensitive and volatile Iam delighted to share with you all that our exports reached the highest level withbusiness activities in the history of our company touching to Rs. 23.67 Cr during the F.Y.2016-17 ( Against the Export Figure of Rs. 18.64Cr for the F.Y. 2015-16) With the growingproduct portfolio our company now enjoys the number one position in many regions of theAfrican market.

New marketing techniques coupled with efficient promotional campaigns have made way forour newly developed products not only in the Africa market but also in other marketsacross the globe.

You will be happy to note that we have made a substantial progress on ourPharmaceutical plant at Addis Ababa Ethiopia. For the further development of this plantour company is going to invest huge amount to establish dedicated Cephalosporin facilityin Ethioipia. We should be able to successfully complete this project during the nextfinancial year.

I strongly believe that with these expanding business horizons we shall be able toachieve greater heights in exports in this financial year. Since all our exports arenearly dollar dominated there is a probability of this US Dollar volatility affecting ouroverall profitability. But we assure you we are taking every step to minimize the impactof the same.

Lastly I intend to reassure our pledge and commitments to all our stakeholders and weshall always thrive for the same. Thank you all for attending this Annual General Meetingand wishing all of you a Diwali Greeting & Happy New Year.

Mukund P. Mehta

Managing Director